Login / Signup

Impact of the COVID-19 Pandemic on Inappropriate Use of the Emergency Department.

Abelardo Claudio Fernández ChávezJesús María Aranaz-AndresMiriam Roncal-RedinFernando Roldán MollMaría Jesús Estévez RuedaPatricia Alva GarcíaYolanda Aranda GarcíaDiego San Jose-Sarasnull On Behalf Health Outcomes Research Group Of The Instituto Ramón Y Cajal de Investigación Sanitaria Irycis
Published in: Microorganisms (2023)
Background : Inappropriate use of the emergency department (IEDU)-consisting of the unnecessary use of the resource by patients with no clinical need-is one of the leading causes of the loss of efficiency of the health system. Specific contexts modify routine clinical practice and usage patterns. This study aims to analyse the influence of COVID-19 on the IEDU and its causes. Methods : A retrospective, cross-sectional study conducted in the emergency department of a high-complexity hospital. The Hospital Emergency Suitability Protocol (HESP) was used to measure the prevalence of IEDU and its causes, comparing three pairs of periods: (1) March 2019 and 2020; (2) June 2019 and 2020; and (3) September 2019 and 2020. A bivariate analysis and multivariate logistic regression models, adjusted for confounding variables, were utilized. Results : In total, 822 emergency visits were included (137 per period). A total prevalence of IEDU of 14.1% was found. There was a significant decrease in IEDU in March 2020 (OR: 0.03), with a prevalence of 0.8%. No differences were found in the other periods. A mistrust in primary care was the leading cause of IEDU (65.1%). Conclusions : The impact of COVID-19 reduced the frequency of IEDU during the period of more significant population restrictions, with IEDU returning to previous levels in subsequent months. Targeted actions in the field of population education and an improvement in primary care are positioned as strategies that could mitigate its impact.
Keyphrases
  • emergency department
  • primary care
  • clinical practice
  • coronavirus disease
  • risk factors
  • healthcare
  • sars cov
  • adverse drug
  • public health
  • randomized controlled trial
  • acute care
  • drug delivery